BetterLife Pharma (STU:NPAU) Research & Development : €0.39 Mil (TTM As of Jan. 2024)

View and export this data going back to 2018. Start your Free Trial

What is BetterLife Pharma Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. BetterLife Pharma's Research & Development for the three months ended in Jan. 2024 was €0.13 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jan. 2024 was €0.39 Mil.

BetterLife Pharma Research & Development Historical Data

The historical data trend for BetterLife Pharma's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BetterLife Pharma Research & Development Chart

BetterLife Pharma Annual Data

Trend

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Jan24

Research & Development

Get a 7-Day Free Trial

0.04

0.18

3.80

1.85

0.39

BetterLife Pharma Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Research & Development	Get a 7-Day Free Trial															0.30	0.05	0.13	0.09	0.13

BetterLife Pharma Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.39 Mil.

BetterLife Pharma (STU:NPAU) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

BetterLife Pharma Research & Development Related Terms

Thank you for viewing the detailed overview of BetterLife Pharma's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

BetterLife Pharma (STU:NPAU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BetterLife Pharma Inc (STU:NPAU) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

BETRF:USA NPAU:Germany BETR:Canada

Address

1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6

Website

https://www.abetterlifepharma.com

BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumors to treat various types of cancer.

BetterLife Pharma (STU:NPAU) Headlines

No Headlines